GLP-3 RT 20mg Peptides
Purpose-built for disciplined research, this vial delivers consistent performance where precision matters most.
Primavora GLP-3 RT is supplied as a lyophilized peptide vial designed for laboratory workflows that require clarity, control, and traceability. This single-ingredient format provides a total content of 20mg per vial, presented as an unflavored, freeze-dried powder that supports stability during storage and handling.
- Each vial contains 20mg of GLP-3 RT, supplied for research into receptor engagement, signaling dynamics, stability profiles, and structure-function relationships under controlled experimental conditions.
This non-edible format is intended for technical applications where researchers value predictable preparation and method development. The lyophilized presentation enables measured reconstitution according to lab protocols, supporting clean handling, accurate aliquoting, and reproducible setup across repeated trials. Whether used for in vitro exploration, assay optimization, or investigative modeling, the emphasis is on consistency and lot-to-lot reliability so results can be evaluated with confidence.
Every vial is produced with careful attention to peptide integrity—from material selection to processing and packaging—to help preserve sequence fidelity and minimize variability. Lot coding supports full traceability within your documentation chain, and each batch is assessed for identity and purity by qualified analytical methods. Clear labeling, protective packaging, and storage guidance are provided to help maintain compound quality from receipt through use.
Primavora operates with a straightforward standard: quality compounds, professional presentation, and transparent documentation that supports serious research. As a USA-based supplier, we prioritize rigorous handling procedures and independent verification, offering researchers a dependable source for GLP-class peptides and related laboratory materials.
Quality & Compliance
- Identity and purity verified by independent analytical testing
- Lot-traceable packaging and clear labeling for streamlined records
- Handled in controlled environments to support material integrity
- Manufactured and fulfilled in the USA
For laboratory research only. Not for human consumption, medical, or veterinary use. Use only by qualified professionals in appropriate research settings.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-3 RT?
GLP-3 RT is not a standard pharmacology name, and on research-vendor sites it is often used as shorthand for a retatrutide-style multi-incretin compound. Because that naming is vendor-dependent, the exact identity should be checked on the product page or certificate of analysis. It should therefore be described cautiously as a multi-pathway metabolic research compound.
What is GLP-3 RT typically studied for?
Compounds sold under this label are generally discussed for appetite, glucose regulation, energy expenditure, and multi-receptor incretin signaling. A careful FAQ should avoid presenting the shorthand as if it were a formal drug name and instead tell readers to verify the exact active ingredient before designing research around it.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Prima Vora are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
